CJC-1295 with DAC + Ipamorelin
Get CJC-1295 with DAC + IpamorelinA growth-hormone-axis pairing: CJC-1295 with DAC (the longer-acting form) combined with ipamorelin, a selective GH secretagogue. Sold as a single bundle by PSPeptides; each component's research profile is covered on its own page.
Composition
What's in CJC-1295 with DAC + Ipamorelin?
CJC-1295 with DAC + Ipamorelin is a blend — it combines these research peptides, sold together as one item:
- CJC-1295 (without DAC / modified GRF 1-29)· 5mg per 10mg vial· GHRH receptor agonist driving pulsatile GH release
- Ipamorelin· Common pairing· Ghrelin receptor (GHS-R) agonist amplifying GH release
The evidence
What the research says about each peptide in CJC-1295 with DAC + Ipamorelin
A blend is only as studied as its parts. The reported findings below come from each peptide’s own research — grouped by compound so you always know which one a finding belongs to, and every claim links to the source it came from.
GHRH receptor agonist driving pulsatile GH release
- CJC-1295 increases plasma GH 2-10-fold for 6+ days and IGF-1 1.5-3-fold for 9-11 days 60/100Rated 60/100Source typeSpecialist communityIndependent sourcesstill being verifiedEvery claim links to the page it came from, and stronger sources rate higher. Full methodology →↗ source
- CJC-1295 raised GH 2-10-fold for 6+ days and IGF-1 1.5-3-fold for 9-11 days after single injection 60/100Rated 60/100Source typeSpecialist communityIndependent sourcesstill being verifiedEvery claim links to the page it came from, and stronger sources rate higher. Full methodology →↗ source
- CJC-1295 + Ipamorelin produce sustained GH elevation with favorable safety profile in early trials 60/100Rated 60/100Source typeSpecialist communityIndependent sourcesstill being verifiedEvery claim links to the page it came from, and stronger sources rate higher. Full methodology →↗ source
- CJC-1295 + Ipamorelin showed sustained GH elevation with favorable safety profile in early trials (investigational) 60/100Rated 60/100Source typeSpecialist communityIndependent sourcesstill being verifiedEvery claim links to the page it came from, and stronger sources rate higher. Full methodology →↗ source
Ipamorelin
8 sourced studiesGhrelin receptor (GHS-R) agonist amplifying GH release
- Dose-proportional stimulation of growth hormone release across a range of infusion doses 92/100Rated 92/100Source typePeer-reviewed studyIndependent sources1Every claim links to the page it came from, and stronger sources rate higher. Full methodology →↗ source
- Short terminal half-life (~2 hours) and dose-proportional pharmacokinetics 92/100Rated 92/100Source typePeer-reviewed studyIndependent sources1Every claim links to the page it came from, and stronger sources rate higher. Full methodology →↗ source
- Selective growth hormone secretagogue activity (first selective GH secretagogue) 88/100Rated 88/100Source typePeer-reviewed studyIndependent sources1Every claim links to the page it came from, and stronger sources rate higher. Full methodology →↗ source
- Stimulation of natural growth hormone release 60/100Rated 60/100Source typeSpecialist communityIndependent sources1Every claim links to the page it came from, and stronger sources rate higher. Full methodology →↗ source
- Enhanced lipolysis and fat metabolism 60/100Rated 60/100Source typeSpecialist communityIndependent sources1Every claim links to the page it came from, and stronger sources rate higher. Full methodology →↗ source
- Improved muscle protein synthesis and recovery 60/100Rated 60/100Source typeSpecialist communityIndependent sources1Every claim links to the page it came from, and stronger sources rate higher. Full methodology →↗ source
Reported routines
- 100–250 mcg once daily SC (research: 100–300 mcg 2–3×/day) 60/100Rated 60/100Source typeSpecialist communityIndependent sources1Every claim links to the page it came from, and stronger sources rate higher. Full methodology →↗ source
Free: The Peptide Stack Cheat-Sheet
See where CJC-1295 with DAC + Ipamorelin fits — the most-used combinations, dosing notes from the research, and what to check before you buy.
No spam. Unsubscribe anytime.
Get CJC-1295 with DAC + Ipamorelin
Compare research-grade suppliers with third-party COAs and published purity data. For in-vitro and laboratory research use only — not for human consumption, diagnosis, or treatment.
Wondering how CJC-1295 with DAC + Ipamorelin pricing compares across suppliers? Our original market data shows the full picture.
See the State of the Peptide Market 2026 →